A novel ARDS therapeutic targeting the Ang1-Tie2 pathway and development of a companion diagnostic using machine learning to improve both the diagnosis and treatment of ARDS patients
Time: 9:40 am
day: Day One
Details:
- Development of Ang1-C4bp: a novel therapeutic for ARDS
- The importance of Ang1-Tie2 in ARDS treatment in both COVID and non-COVID patients
- Collaboration between Mannin, DNAStack, Biosymmetrics to develop a novel companion diagnostic for ARDS utilizing machine learning
- Discussion of clinical plans and timeline
